Heparin‐induced thrombocytopaenia · adults with CVCs
It is very uncertain whether heparin changes heparin‐induced thrombocytopaenia compared with normal saline solution locking (very low certainty).
1 finding from 1 review
Major bleeding events: unfractionated heparin · kidney transplant recipients
Heparin showed no clear difference in major bleeding events: unfractionated heparin compared with placebo (low certainty).
1 finding from 1 review
Major bleeding events: all heparin · kidney transplant recipients
Heparin showed no clear difference in major bleeding events: all heparin compared with placebo (low certainty).
1 finding from 1 review
Readmissions to intensive care: all heparin · kidney transplant recipients
It is very uncertain whether heparin changes readmissions to intensive care: all heparin compared with placebo (very low certainty).
1 finding from 1 review
Occlusion of CVC (combining participant and catheter as unit of analysis) Blood withdrawing · adults with CVCs
Heparin may leads to lower occlusion of CVC (combining participant, and catheter as unit of… compared with normal saline solution locking (low certainty).
1 finding from 1 review
Duration of catheter patency (days; combining participant and catheter as unit of analysis) Blood withdrawing · adults with CVCs
1 finding from 1 review
CVC‐related bloodstream infections (positive microbiological culture, participant as unit of analysis) · adults with CVCs
It is very uncertain whether heparin changes CVC‐related bloodstream infections (positive microbiological… compared with normal saline solution locking (very low certainty).
1 finding from 1 review
All‐cause mortality · adults with CVCs
It is very uncertain whether heparin changes mortality compared with normal saline solution locking (very low certainty).
1 finding from 1 review
Haemorrhage · adults with CVCs
It is very uncertain whether heparin changes haemorrhage from any site compared with normal saline solution locking (very low certainty).
1 finding from 1 review
Intraventricular haemorrhage · preterm infants at risk of intraventricular haemorrhage
It is very uncertain whether heparin changes any Intraventricular Haemorrage (IVH) compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Severe intraventricular haemorrhage · preterm infants at risk of intraventricular haemorrhage
Heparin showed no clear difference in severe IVH compared with placebo/no treatment (low certainty).
1 finding from 1 review
Neonatal mortality · preterm infants at risk of intraventricular haemorrhage
Heparin showed no clear difference in neonatal mortality (all‐cause) compared with placebo/no treatment (low certainty).
1 finding from 1 review
All‐cause mortality · patients with non‐ST elevation acute coronary syndromes
Heparin showed no clear difference in all‐cause mortality compared with placebo (low certainty).
1 finding from 1 review
Myocardial infarction · patients with non‐ST elevation acute coronary syndromes
Heparin may leads to lower incidence of myocardial infarction compared with placebo (low certainty).
1 finding from 1 review
Recurrent angina · patients with non‐ST elevation acute coronary syndromes
It is very uncertain whether heparin changes recurrent angina compared with placebo (very low certainty).
1 finding from 1 review
Incidence of revascularization procedures · patients with non‐ST elevation acute coronary syndromes
Heparin showed no clear difference in incidence of revascularization procedures compared with placebo (low certainty).
1 finding from 1 review
Major hemorrhage · patients with non‐ST elevation acute coronary syndromes
Heparin showed no clear difference in major hemorrhage compared with placebo (low certainty).
1 finding from 1 review
Heparin‐induced thrombocytopaenia · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1 finding from 1 review
All‐cause mortality · people undergoing bariatric surgery
1 finding from 1 review
VTE‐related mortality4 · people undergoing bariatric surgery
1 finding from 1 review